INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Commencement of a Class Action Lawsuit Against ProNAi Therapeut...
December 29 2016 - 1:04PM
Business Wire
The following statement is being issued by Levi & Korsinsky,
LLP:
To: All persons or entities who purchased shares of ProNAi
Therapeutics, Inc. (“ProNAi”) (NASDAQ:DNAI) between July 15, 2015 and June 6, 2016 (the “Class
Period”). You are hereby notified that a
securities class action lawsuit has been commenced in the USDC for
the Southern District of New York. To get more information go
to:
http://www.zlk.com/pslra/pronai-therapeutics-inc
or contact Joseph E. Levi, Esq. either via email at
jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877)
363-5972. There is no cost or obligation to you.
The complaint alleges that, throughout the Class Period, ProNAi
made materially false and misleading statements about the potential
and efficacy of its drug product candidate PNT2258 in the company’s
public filings, which caused ProNAi’s stock price to be
artificially inflated throughout the Class Period, thus harming
investors.
On June 6, 2016, ProNAi revealed that the Phase 2 clinical
trials of PNT2258 failed to produce sufficient efficacy results to
justify continued clinical development of the drug and, thus,
ProNAi was suspending clinical development of PNT2258. Following
this news, shares of ProNAi fell more than 67 percent.
If you suffered a loss in ProNAi you have until January 9, 2017 to request that the Court
appoint you as lead plaintiff. Your ability to share in any
recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New
York, New Jersey, California, Connecticut, and Washington D.C. The
firm’s attorneys have extensive expertise and experience
representing investors in securities litigation, and have recovered
hundreds of millions of dollars for aggrieved shareholders.
Attorney advertising. Prior results do not guarantee similar
outcomes.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161229005258/en/
Levi & Korsinsky, LLPJoseph E. Levi, Esq., 212-363-7500Toll
Free: 877-363-5972Fax: 212-363-7171www.zlk.com
Sierra Oncology (NASDAQ:SRRA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Sierra Oncology (NASDAQ:SRRA)
Historical Stock Chart
From Sep 2023 to Sep 2024